IL1B and psoriasis: The blockage of IL-1β results in the retarded development of acute and chronic inflammatory disorders, such as rheumatoid arthritis, psoriasis, atopic dermatitis, pharyngitis, aphthous stomatitis, and atherosclerosis, among others [35].